论文部分内容阅读
目的探讨分析卡托普利与氯沙坦治疗肾性高血压的临床疗效及用药安全。方法将我院收治的肾性高血压患者84例,随机分为两组,实验组42例使用卡托普利进行治疗,对照组42例使用氯沙坦进行治疗,观察对比两组肾性高血压疾病的治疗效果。结果实验组和对照组经过治疗血压均比治疗前下降,但实验组治疗肾性高血压疾病的血压下降更为显著,p<0.05,差异有统计学意义。结论卡托普利与氯沙坦都能有效治疗肾性高血压,卡托普利的效果更加显著,价格方面也具有优势,但氯沙坦治疗肾性高血压缓慢而持久,不良反应咳嗽发生率低于卡托普利。
Objective To investigate the clinical efficacy and safety of captopril and losartan in the treatment of renal hypertension. Methods Eighty-four patients with renal hypertension admitted to our hospital were randomly divided into two groups. In the experimental group, 42 patients were treated with captopril, and 42 patients in the control group were treated with losartan. The renal hypertrophy was observed in two groups Therapeutic effect of blood pressure disease. Results The blood pressure of experimental group and control group decreased after treatment, but the blood pressure of experimental group was significantly lower than that of the control group (p <0.05), the difference was statistically significant. Conclusions Both captopril and losartan can effectively treat renal hypertension, the effect of captopril is more significant, and the price is also superior. However, losartan treatment of renal hypertension slow and long-lasting, adverse reactions cough Rate lower than captopril.